You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Three interchangeable needles — the FNA, FNB, and FNF — allow for predictable biliary access, fine needle aspiration, fine needle biopsy, fiducial placement and improved procedural workflow in one procedure. 1-8
For more than 40 years, Medtronic has been the world leader in designing and manufacturing advanced energy-based medical systems and accessories, such as Cool-tip™ E-Series radiofrequency ablation systems and the new Emprint™ HP Ablation system with Thermosphere™ technology.
The Emprint™ HP Ablation system enables a minimally invasive procedure with few side effects15, fast recovery time16,17, high accuracy18, and predictable margins.19
The Emprint™ HP Ablation zone app puts the ablation setting details you need in the palm of your hand. With comprehensive ex vivo and in vivo ablation zone reference values, you can create tailored ablation zones20 with confidence.
What’s more powerful than having the right technology for soft-tissue ablation?
Be the first to deliver the power of choice in thermal ablation.
The Barrx™ radiofrequency ablation system includes technology for treating Barrett's esophagus.21
TR110601 Rev 01 DV Report Dated November 11, 2011 (Data on file)
PPQ Report: TR-20009 Rev 01 dated March 9, 2015 (Data on File)
AA study report: TR-20003 Rev 01 dated March 18, 2015 (Data on file)
510k study TR100509 Rev 01 dated September 21, 2010 (Data on file).
AA study TR100706 Rev 01 dated January 6, 2011 (Data on file).
AA study TR110716 Rev 01 dated December 16, 2011 (Data on file).
DV/PPQ report: TR110601 Rev 01 dated November 11, 2011 (Data on file).
Based on internal testing data,V-0450-02 (Access DVT Report) dated February 8, 2019 (Data on file).
Internal test report #1085, July 8, 2014 and Internal test report #1090, September 25, 2014 (Data on file).
DiMaio CJ, Kolb JM, Benias PC, et al. Initial experience with a novel EUS-guided core biopsy needle (SharkCore™): results of a large North American multicenter study. Endosc Int Open. 2016;4(9):E974–E979.
Jovani M, Abidi WM, Lee LS. Novel fork-tip needles versus standard needles for EUS-guided tissue acquisition from solid masses of the upper GI tract: a matched cohort study. Scand J Gastroenterol. 2017;52(6–7):784–787.
Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is two betterthan one? A comparison of EUS-FNA efficiency of single-vs multi-needle platforms. Gastrointest Endosc. 2013;77(5S):AB179.
Moore JZ, Zhang Q, McGill CS, et al. Modeling of the plane needle cutting edge rake and inclination angles for biopsy. J Manuf Sci Eng 2010;132:051005-1-051005-8.22b.
Kothari S, Kothari T, et al. 234, Endoscopic Ultrasound (EUS)-Guided Fiducial Placement for Stereotactic Body Radiotherapy (SBRT): First Global Experience with a New 22-Gauge “Pre-loaded” EUS Fiducial Needle The American Journal of Gastroenterology, vol 110, Supplement 1 October 2015
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006 Mar;243(3):321–328.
Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia. 2015;31(7):749–757.
Zhang M. Ma H, Zhang J, He L, Ye X, Li X. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta analysis. Onco Targets Ther. 2017;10:4829–4839.
De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.
Vogl, TJ., Basten, LM., Nour-Eldin, A., Kaltenbach, B., Bodelle, B., Wichmann, JL., Ackermann, H., Naguib, NNN. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zones. Int J Hyperthermia. 2018 Jun;34(4):492-500.
Internal memo RE00275376 Emprint vs Emprint HP Ablation Performance Comparison Memo, dated June 2020
Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867-876.
ARCHIMEDES™* is property of AMG GI, a Q3 Medical Company
™* Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.